![Assisted Reproductive Technology Market](https://cdn.vantagemarketresearch.com/report/cover/Assisted-Reproductive-Technology-Market.webp)
Assisted Reproductive Technology Market
Assisted Reproductive Technology Market - Global Industry Assessment & Forecast
Segments Covered
By Product Instrument, Accessory & Disposable, Reagents & Media
By Technology In Vitro-Fertilization, Artificial Insemination, Other Technologies
By End User Fertility Clinic, Hospital, Surgical Center, Clinical Research Institute
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
![]() |
2022 |
![]() |
2023 - 2030 |
![]() |
2017 - 2021 |
![]() |
USD 25.1 Billion |
![]() |
USD 40.9 Billion |
![]() |
6.3% |
![]() |
Asia Pacific |
![]() |
Europe |
Customization Offered
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst
Sr. No. | Offering | Report Coverage |
1. | Market Size | In terms of Revenue (USD Million) |
2. | Historic Data | 2017 to 2021 |
3. | Forecast Data | 2023 to 2030 |
4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
5. | Market Attractiveness Analysis | Yes |
6. | Segment Analysis | Maximum Segments |
7. | Regional Coverage | 5 Regions |
8. | Country Coverage | Top 22 Countries |
9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
10. | Porter’s Five Forces Analysis | Yes. |
11. | Value Chain Analysis | Yes |
12. | PEST Analysis | Yes |
13. | Regulatory Landscape | Yes |
14. | Technology Landscape | Yes |
15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
16. | Top startups to watch out for | Yes |
17. | Top 3 Trends to Watch | Yes |
18. | Top 3 Strategies Followed by Major Players | Yes |
19. | Top 3 Predictions by Vantage Market Research | Yes |
20. | Discussion Guide | Yes |
21. | Key Primary Respondents - VERBATIM | Yes |
22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
23. | Others/Miscellaneous |
FAQ
Frequently Asked Question
What is the global demand for Assisted Reproductive Technology in terms of revenue?
-
The global Assisted Reproductive Technology valued at USD 25.1 Billion in 2022 and is expected to reach USD 40.9 Billion in 2030 growing at a CAGR of 6.3%.
Which are the prominent players in the market?
-
The prominent players in the market are Thermo Fisher Scientific Inc. (U.S.), Oxford Gene Technology IP Ltd. (UK), Genea Biomedx (Australia), The Cooper Companies Inc. (U.S.), Inception Sciences Inc. (U.S.), Fujifilm Holdings Corporation (Japan), Vitrolife AB (Sweden), Progyny Inc. (U.S.), Merck KGAA (Germany), Cook Group (U.S.).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 6.3% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Assisted Reproductive Technology include
- Increase in prevalence of infertility rate
Which region accounted for the largest share in the market?
-
Europe was the leading regional segment of the Assisted Reproductive Technology in 2022.